|
Valoración de DCF de Hookipa Pharma Inc. (Hook)
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
HOOKIPA Pharma Inc. (HOOK) Bundle
¿Busca evaluar el valor intrínseco de Hookipa Pharma Inc.? Nuestra calculadora DCF Hook integra datos del mundo real con extensas características de personalización, lo que le permite refinar sus pronósticos y mejorar sus estrategias de inversión.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 11.9 | 19.6 | 18.4 | 14.2 | 20.1 | 24.0 | 28.6 | 34.1 | 40.6 | 48.4 |
Revenue Growth, % | 0 | 63.99 | -5.8 | -22.76 | 41.27 | 19.17 | 19.17 | 19.17 | 19.17 | 19.17 |
EBITDA | -39.1 | -39.1 | -70.1 | -60.4 | -77.3 | -24.0 | -28.6 | -34.1 | -40.6 | -48.4 |
EBITDA, % | -327.36 | -199.89 | -380.13 | -423.86 | -384.24 | -100 | -100 | -100 | -100 | -100 |
Depreciation | 3.1 | 4.2 | 4.6 | 3.6 | 3.6 | 5.5 | 6.6 | 7.8 | 9.3 | 11.1 |
Depreciation, % | 25.68 | 21.19 | 25.15 | 25.28 | 17.65 | 22.99 | 22.99 | 22.99 | 22.99 | 22.99 |
EBIT | -42.2 | -43.3 | -74.8 | -64.0 | -80.9 | -24.0 | -28.6 | -34.1 | -40.6 | -48.4 |
EBIT, % | -353.04 | -221.08 | -405.28 | -449.14 | -401.88 | -100 | -100 | -100 | -100 | -100 |
Total Cash | 113.2 | 143.2 | 66.9 | 113.4 | 117.1 | 24.0 | 28.6 | 34.1 | 40.6 | 48.4 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 9.7 | 20.7 | 21.2 | 22.0 | 19.3 | 22.9 | 27.3 | 32.5 | 38.8 | 46.2 |
Account Receivables, % | 81.45 | 105.48 | 114.73 | 154.48 | 95.74 | 95.44 | 95.44 | 95.44 | 95.44 | 95.44 |
Inventories | -8.2 | -15.5 | -15.3 | -.4 | .0 | -11.2 | -13.4 | -15.9 | -19.0 | -22.6 |
Inventories, % | -68.58 | -79.4 | -82.73 | -2.94 | 0 | -46.73 | -46.73 | -46.73 | -46.73 | -46.73 |
Accounts Payable | .9 | 8.0 | 8.8 | 5.5 | 12.5 | 9.4 | 11.3 | 13.4 | 16.0 | 19.1 |
Accounts Payable, % | 7.9 | 40.9 | 47.5 | 38.51 | 62.09 | 39.38 | 39.38 | 39.38 | 39.38 | 39.38 |
Capital Expenditure | -2.0 | -2.4 | -12.6 | -5.0 | -4.2 | -7.3 | -8.7 | -10.4 | -12.4 | -14.8 |
Capital Expenditure, % | -16.74 | -12.11 | -68.2 | -35.21 | -20.66 | -30.58 | -30.58 | -30.58 | -30.58 | -30.58 |
Tax Rate, % | -0.45314 | -0.45314 | -0.45314 | -0.45314 | -0.45314 | -0.45314 | -0.45314 | -0.45314 | -0.45314 | -0.45314 |
EBITAT | -42.2 | -43.3 | -74.8 | -64.0 | -81.3 | -24.0 | -28.6 | -34.1 | -40.6 | -48.4 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -41.7 | -38.0 | -82.8 | -84.4 | -72.5 | -21.3 | -31.2 | -37.2 | -44.3 | -52.8 |
WACC, % | 7.43 | 7.43 | 7.43 | 7.43 | 7.43 | 7.43 | 7.43 | 7.43 | 7.43 | 7.43 |
PV UFCF | ||||||||||
SUM PV UFCF | -146.9 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -54 | |||||||||
Terminal Value | -991 | |||||||||
Present Terminal Value | -692 | |||||||||
Enterprise Value | -839 | |||||||||
Net Debt | -111 | |||||||||
Equity Value | -729 | |||||||||
Diluted Shares Outstanding, MM | 9 | |||||||||
Equity Value Per Share | -77.11 |
What You Will Receive
- Comprehensive Financial Model: HOOKIPA Pharma Inc.’s actual data facilitates accurate DCF valuation.
- Complete Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
- Real-Time Calculations: Automatic updates provide immediate feedback as adjustments are made.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
- Flexible and Reusable: Designed for adaptability, allowing for repeated applications in detailed forecasting.
Key Features
- Customizable Clinical Parameters: Adjust essential inputs such as trial success rates, market penetration, and R&D expenditures.
- Instant Valuation Calculations: Provides real-time insights into intrinsic value, NPV, and other financial metrics.
- High-Precision Analytics: Leverages HOOKIPA Pharma's actual financial data for credible valuation results.
- Effortless Scenario Testing: Easily evaluate various hypotheses and analyze their impacts side by side.
- Efficiency Booster: Streamlines the valuation process, removing the necessity for complex model construction.
How It Works
- Step 1: Download the prebuilt Excel template containing HOOKIPA Pharma Inc.'s (HOOK) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the recalculated results, including HOOKIPA Pharma Inc.'s (HOOK) intrinsic value.
- Step 5: Make well-informed investment choices or create reports based on the outputs.
Why Choose This Calculator for HOOKIPA Pharma Inc. (HOOK)?
- Accurate Data: Utilize real HOOKIPA Pharma financials for trustworthy valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-configured calculations remove the hassle of starting from the ground up.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Easy-to-navigate design and clear instructions ensure accessibility for all users.
Who Should Use HOOKIPA Pharma Inc. (HOOK)?
- Individual Investors: Gain insights to make informed decisions about investing in HOOKIPA Pharma Inc. stock.
- Financial Analysts: Enhance valuation methodologies with comprehensive financial models tailored for HOOK.
- Consultants: Provide clients with accurate and timely valuation analyses of HOOKIPA Pharma Inc.
- Business Owners: Learn how biotech companies like HOOKIPA are valued to inform your business strategies.
- Finance Students: Explore real-world valuation techniques using data from HOOKIPA Pharma Inc. and similar firms.
What the Template Contains
- Pre-Filled DCF Model: HOOKIPA Pharma Inc.’s financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate HOOKIPA Pharma Inc.’s profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.